Published in Int J Cancer on January 15, 2013
The challenge of attributing causality in cancer of unknown primary. Int J Cancer (2013) 1.07
Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site. BMC Cancer (2014) 0.88
Bone metastases of unknown origin: epidemiology and principles of management. J Orthop Traumatol (2015) 0.78
A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin. Medicine (Baltimore) (2015) 0.75
Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model. Sci Rep (2016) 0.75
Survival in carcinoma of unknown primary to neck nodes treated with neck dissection and radiotherapy. Ann Med Health Sci Res (2014) 0.75
The challenges of understanding cancer of unknown primary. Int J Cancer (2013) 0.75
Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence. World J Surg (2017) 0.75
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med (2006) 9.85
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med (2003) 7.35
Harmful impact of EU clinical trials directive. BMJ (2006) 4.85
Gestational age at birth and mortality in young adulthood. JAMA (2011) 3.31
Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus. Clin Cancer Res (2013) 3.22
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial. Lancet Oncol (2013) 2.70
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med (2010) 2.58
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells. Eur Urol (2007) 2.42
Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol (2012) 2.32
Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study. BMJ (2013) 2.16
Inequities in CHD incidence and case fatality by neighborhood deprivation. Am J Prev Med (2007) 2.16
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12
Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics (2008) 2.11
SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res (2005) 2.05
IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry (2014) 2.05
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry (2013) 2.03
Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study. Arch Gen Psychiatry (2012) 2.00
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF. Mol Ther (2010) 1.91
Neighborhood deprivation and cardiovascular disease risk factors: protective and harmful effects. Scand J Public Health (2006) 1.85
Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation (2012) 1.82
Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry (2014) 1.82
Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet (2010) 1.78
Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75
Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res (2002) 1.74
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin Cancer Res (2002) 1.74
Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation (2011) 1.73
Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum (2009) 1.73
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. Lancet Oncol (2009) 1.70
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients. Cancer Res (2010) 1.69
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells. Mol Ther (2007) 1.68
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus. Mol Ther (2011) 1.60
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol (2008) 1.58
Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer. Mol Ther (2012) 1.57
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology (2005) 1.56
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer. Cancer (2006) 1.53
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One (2011) 1.50
Low-linking social capital as a predictor of mental disorders: a cohort study of 4.5 million Swedes. Soc Sci Med (2006) 1.50
Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost (2013) 1.50
Preterm birth and risk of medically treated hypothyroidism in young adulthood. Clin Endocrinol (Oxf) (2011) 1.48
Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum (2009) 1.45
Gestational age at birth and risk of testicular cancer. Int J Cancer (2011) 1.45
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol Ther (2003) 1.43
Low linking social capital as a predictor of coronary heart disease in Sweden: a cohort study of 2.8 million people. Soc Sci Med (2005) 1.42
Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry (2013) 1.40
Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure. Scand Cardiovasc J (2014) 1.40
Mortality causes in cancer patients with type 2 diabetes mellitus. Eur J Cancer Prev (2012) 1.39
Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data. Mol Pharm (2010) 1.36
Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors. Clin Cancer Res (2010) 1.33
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus. Cancer Res (2012) 1.29
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. Mol Ther (2002) 1.28
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients. Cancer Res (2012) 1.28
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors. Int J Cancer (2011) 1.26
Physical activity, exercise and self-rated health: a population-based study from Sweden. BMC Public Health (2008) 1.26
Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. Cancer Res (2009) 1.24
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients. Mol Ther (2013) 1.22
Within-family environmental transmission of drug abuse: a Swedish national study. JAMA Psychiatry (2013) 1.20
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Hum Gene Ther (2007) 1.19
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance. Mol Ther (2012) 1.18
Oncolytic viruses for induction of anti-tumor immunity. Curr Pharm Biotechnol (2012) 1.18
Modified adenoviruses for cancer gene therapy. Int J Cancer (2004) 1.18
Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull (2012) 1.18
Risk of hypertension among young adults who were born preterm: a Swedish national study of 636,000 births. Am J Epidemiol (2011) 1.18
Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions. J Virol (2011) 1.17
Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res (2002) 1.15
Cancer risks in ulcerative colitis patients. Int J Cancer (2008) 1.15
Risk of asthma in young adults who were born preterm: a Swedish national cohort study. Pediatrics (2011) 1.14
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells. Mol Ther (2006) 1.12
Physical activity and concordance between objective and perceived walkability. Med Sci Sports Exerc (2012) 1.12
Familial risks for type 2 diabetes in Sweden. Diabetes Care (2009) 1.10
Tissue-specific promoters for cancer gene therapy. Expert Opin Biol Ther (2004) 1.10
Neighborhood deprivation and psychiatric medication prescription: a Swedish national multilevel study. Ann Epidemiol (2011) 1.10
Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer (2012) 1.09
The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun (2009) 1.07
Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol (2012) 1.07
High familial risks for cerebral palsy implicate partial heritable aetiology. Paediatr Perinat Epidemiol (2007) 1.07
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models. J Virol (2009) 1.06
Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis (2012) 1.06
Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health (2010) 1.06
The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer (2011) 1.06
Risk of asthma and autoimmune diseases and related conditions in patients hospitalized for obesity. Ann Med (2011) 1.05
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells. Cancer Res (2008) 1.05
Oncolytic vaccinia virus for the treatment of cancer. Expert Opin Biol Ther (2011) 1.04
Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). Int J Oncol (2002) 1.03
Psychosocial working conditions and self-reported long-term illness: a population-based study of Swedish-born and foreign-born employed persons. Ethn Health (2003) 1.03
Adenoviruses for treatment of cancer. Ann Med (2005) 1.03
Preterm birth and psychiatric medication prescription in young adulthood: a Swedish national cohort study. Int J Epidemiol (2010) 1.03
Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford) (2010) 1.03
Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study. J Natl Cancer Inst (2012) 1.03
The influence of age at migration and length of residence on self-rated health among Swedish immigrants: a cross-sectional study. Ethn Health (2009) 1.02
Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil (2005) 1.02
An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism. Virology (2004) 1.02
The impact of country of birth and time in Sweden on overweight and obesity: a population-based study. Scand J Public Health (2005) 1.02
Risk of obesity in immigrants compared with Swedes in two deprived neighbourhoods. BMC Public Health (2009) 1.01
Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol (2012) 1.01
Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans. Adv Cancer Res (2012) 1.00
Incidence of schizophrenia or other psychoses in first- and second-generation immigrants: a national cohort study. J Nerv Ment Dis (2006) 1.00
A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses. J Virol (2012) 1.00
Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer (2012) 0.99
Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am J Gastroenterol (2009) 0.99
Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus. Mol Ther (2011) 0.98